Pfizer and BioNTech start trials of new Omicron-specific jab
Published
The companies have adapted their original vaccine to target the fast-spreading variant.
Full ArticlePublished
The companies have adapted their original vaccine to target the fast-spreading variant.
Full ArticlePfizer and BioNTech have adapted their original vaccine to target the fast-spreading variant.